Home > Press > First U-M employees move to new North Campus Research Complex
Lisa Kiel, office manager for U-M's Institutional Review Boards, is surrounded by boxes at her new office at the North Campus Research Complex. Kiel and about 30 other IRB employees will work in their new offices at NCRC for the first time today. |
Abstract:
About 30 staff now working at former Pfizer property, with hundreds more following soon
The first group of University of Michigan employees moved into new permanent workspaces today at the North Campus Research Complex (NCRC), the former Pfizer property purchased by the University in June 2009.
This "pioneer" group moved into the office buildings near the southeast corner of Huron Parkway and Plymouth Road. They are all existing University of Michigan staff in the U-M's Institutional Review Boards office, known as IRBMED.
IRBMED oversees any research involving human participants that is conducted at the Medical School and some other areas of U-M and is responsible for protecting the rights and welfare of research volunteers.
They are among the 300 employees expected to move into NCRC during the month of April, all from units that support the University's research community in multiple functions.
"Today is a major milestone in the development of the North Campus Research Complex, and we welcome this pioneering group of employees," says Ora Hirsch Pescovitz, M.D., executive vice president for medical affairs and one of the leading planners for the NCRC site.
"Our first phase co-locates several units that often work together to support the University's research community. As researchers begin to move to NCRC in coming months and years, they will benefit from having these research support functions close by."
But Pescovitz says today's pioneers are just the tip of the iceberg -- the first of thousands of faculty and staff who will use NCRC's facilities to help redefine research at Michigan in the future.
Moving in during April will be employees from the Michigan Institute for Clinical & Health Research (MICHR), the development and clinical trials offices for the U-M Comprehensive Cancer Center, the Cancer Center's SPORE (Specialized Program of Research Excellence) group and the Medical School Office of Research's CRAO (Calendar Review and Analysis Office).
All of these units are moving from off-campus buildings leased by the University. U-M has kept some of those leases, as other U-M units move into the vacated space..
These office-based functions were easily moved into the former Pfizer buildings. The U-M Board of Regents approved on Dec. 17 an $1.8 million project for improvements including painting and new carpet in these structures. Other buildings in the NCRC, especially laboratories, will require more preparation and planning before they can be used.
As the first move-in occurs, researchers at U-M currently are submitting proposals to create grassroots faculty teams that will form interdisciplinary research clusters at NCRC.
The University also has identified the first two technology anchors to develop at NCRC. The first is a world-class program in biointerfaces, which includes an interdisciplinary mix of nanotechnology, microfluidics and sensors, cell and tissue engineering, and biomaterials and drug delivery. The second is a cutting-edge collaboration in molecular, functional, and structural imaging.
The property remains closed to the public except for selected special events, but those interested can find out more about the planning process for the use of the site at www.umresearchgrowth.org. All are welcome to join an e-mail list that will receive direct updates about progress at NCRC; instructions are available at the Web site, www.umresearchgrowth.org/.
####
For more information, please click here
Contacts:
Media contact:
Mary Masson
Phone: 734-764-2220
Copyright © University of Michigan
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Sensors
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||